Dendritic-cell-based therapeutic cancer vaccines.
Dendritic-cell-based therapeutic cancer vaccines.
复制标题
DOI:
10.1016/j.immuni.2013.07.004
复制
发表时间:
2013-07-25
期刊:
影响因子:
32.4
通讯作者:
Banchereau J
中科院分区:
文献类型:
--
作者:
Palucka K;Banchereau J
The past decade has seen tremendous developments in novel cancer therapies, through targeting of tumor cell-intrinsic pathways whose activity is linked to genetic alterations, as well as the targeting of tumor cell-extrinsic factors such as growth factors. Furthermore, immunotherapies are entering the clinic at an unprecedented speed following the demonstration that T cells can efficiently reject tumors and that their anti-tumor activity can be enhanced with antibodies against immune regulatory molecules (checkpoints blockade). Current immunotherapy strategies include monoclonal antibodies against tumor cells or immune regulatory molecules, cell-based therapies such as adoptive transfer of ex vivo activated T cells and natural killer (NK) cells, and cancer vaccines. Herein, we discuss the immunological basis for therapeutic cancer vaccines and how the current understanding of dendritic cell (DC) and T cell biology might enable development of next-generation curative therapies for patients with cancer.
登录
查看更多内容
影响因子:
15.3
作者:
Bonifaz, L;Bonnyay, D;Mahnke, K;Rivera, M;Nussenzweig, MC;Steinman, RM
通讯作者:
Steinman, RM
影响因子:
7
作者:
Barber GN
通讯作者:
Barber GN
影响因子:
20.3
作者:
Banchereau, Jacques;Thompson-Snipes, Luann;Klechevsky, Eynav
通讯作者:
Klechevsky, Eynav
DOI:
10.1084/jem.185.5.941
发表时间:
1997-03-03
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Dubois B;Vanbervliet B;Fayette J;Massacrier C;Van Kooten C;Brière F;Banchereau J;Caux C
通讯作者:
Caux C
DOI:
10.1007/978-1-4419-1603-7_10
发表时间:
2009-01-01
期刊:
LIPID A IN CANCER THERAPY
影响因子:
--
作者:
Cluff, Christopher W.
通讯作者:
Cluff, Christopher W.